Agilent Technologies, Inc. (NYSE:A) is seeking M&A. Robert McMahon Chief Financial Officer said during the Jefferies 2021 Virtual Global Healthcare Conference, "In terms of M&A, we still have a very strong balance sheet. I think our sweet spot is the Res Bio sizes, but we could do bigger deals than that. We still want to be investment grade. But our area of focus is primarily in the private space. And feel like we know the targeted areas that we want to hit and the activity is very active, valuations are rich, so we'll say more -- no more to -- than we say yes to deals, but feel very confident not only in that space, but potentially a little bigger as well".